Medarex is a biopharmaceutical company founded in 1987 and headquartered in the United States. The company is dedicated to the discovery, development, and potential commercialization of fully human antibody-based therapeutics for severe diseases such as cancer, inflammation, autoimmune, and infectious diseases. Medarex leverages its UltiMAb® technology and product development and clinical manufacturing experience to create a diverse pipeline of antibody products. This positions the company to address unmet healthcare needs globally. Currently, there is no information available regarding the last investment or the investors involved in Medarex.
Medarex
Founded 1987
Princeton, United States
93 employees
Biotechnology
Princeton, United States
93 employees
Biotechnology
General Information
Get notified when Medarex moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Medarex
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Medarex
Taxonomy: biopharmaceutical company, antibody-based therapeutics, cancer treatment, inflammation treatment, autoimmune diseases, infectious diseases, UltiMAb® technology, clinical manufacturing, fully human antibody products, pipeline of antibody products, value building, partner collaborations
No funding data available for Medarex yet.
Get notified when Medarex raises fundingMedarex Alternatives & Competitors
Medarex vs
XBiotech USA, Inc.
United States
Next Generation Antibody Therapy
97 employees
Biotechnology, Health Care
Medarex vs
Dedicated to alleviating human suffering with safer and better antibody therapeutics through innovat...
Post Ipo Equity
Biotechnology, Health Care
Medarex vs
Narval
United States
A new generation of antibody drugs using synthetic antibody mimetic proteins delivered through mucos...
Non Equity Assistance
8 employees
Biotechnology, Health and Wellness
FAQ About Medarex
Medarex is a biopharmaceutical company focused on the discovery, development, and potential commercialization of fully human antibody-based therapeutics to treat life- threatening and debilitating diseases, including cancer, inflammation, autoimmune and infectious diseases. Medarex applies its UltiM...
Medarex was founded in 1987.
Medarex is headquartered in Princeton, United States.
Medarex operates in the following industries: Biotechnology.
Medarex has approximately 93 employees.
Top alternatives and competitors to Medarex include XBiotech USA, Inc., Alder Biopharmaceuticals, Narval, Ability Biotherapeutics, Radiant Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medarex and XBiotech USA, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Medarex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.